Authors: Simmen, U Higelin, J Berger-Buter, K Schaffner, W Lundstrom, K

Citation: U. Simmen et al., Neurochemical studies with St. John's wort in vitro, PHARMACOPS, 34, 2001, pp. S137-S142

Authors: Higelin, J Py-Lang, G Paternoster, C Ellis, GJ Patel, A Dautzenberg, FM

Citation: J. Higelin et al., I-125-antisauvagine-30: a novel and specific high-affinity radioligand forthe characterization of corticotropin-releasing factor type 2 receptors, NEUROPHARM, 40(1), 2001, pp. 114-122

Authors: Dautzenberg, FM Wichmann, J Higelin, J Py-Lang, G Kratzeisen, C Malherbe, P Kilpatrick, GJ Jenck, F

Citation: Fm. Dautzenberg et al., Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: Rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo, J PHARM EXP, 298(2), 2001, pp. 812-819

Authors: Dautzenberg, FM Py-Lang, G Higelin, J Fischer, C Wright, MB Huber, G

Citation: Fm. Dautzenberg et al., Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: Evidence for evolutionary differences, J PHARM EXP, 296(1), 2001, pp. 113-120

Authors: Dautzenberg, FM Huber, G Higelin, J Py-Lang, G Kilpatrick, GJ

Citation: Fm. Dautzenberg et al., Evidence for the abundant expression of arginine 185 containing human CRF2alpha receptors and the role of position 185 for receptor-ligand selectivity, NEUROPHARM, 39(8), 2000, pp. 1368-1376

Authors: Dautzenberg, FM Higelin, J Teichert, U

Citation: Fm. Dautzenberg et al., Functional characterization of corticotropin-releasing factor type 1 receptor endogenously expressed in human embryonic kidney 293 cells, EUR J PHARM, 390(1-2), 2000, pp. 51-59